Judge rejects Sanofi's request to prevent sales of a generic Lovenox

08/26/2010 | Bloomberg Businessweek

U.S. District Judge Emmet Sullivan denied a request by Sanofi-Aventis to prevent an FDA-approved copy of its blood thinner Lovenox from going into the market. The generic was developed by Novartis' Sandoz subsidiary and Momenta Pharmaceuticals. The judge said delaying the distribution of the generic could have a negative effect on the public.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD